Clinical trial
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
NCT00027079 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00027079 |
|---|---|
| Title | Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron) |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Behavioral, Drug |
| Interventions | ondansetron (Zofran), naltrexone (ReVia), Cognitive Behavioral Therapy |
| Enrollment | 360 |
| Start date | Sep 1, 2001 |
| Completion | Aug 1, 2004 |
| First posted | Nov 21, 2001 |
| Last update posted | Dec 10, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: